124 related articles for article (PubMed ID: 35881046)
1. Beta-blocker use and urothelial bladder cancer survival: a Swedish register-based cohort study.
Udumyan R; Botteri E; Jerlstrom T; Montgomery S; Smedby KE; Fall K
Acta Oncol; 2022 Aug; 61(8):922-930. PubMed ID: 35881046
[TBL] [Abstract][Full Text] [Related]
2. Beta-adrenergic receptor blockers and liver cancer mortality in a national cohort of hepatocellular carcinoma patients.
Udumyan R; Montgomery S; Duberg AS; Fang F; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Scand J Gastroenterol; 2020 May; 55(5):597-605. PubMed ID: 32412855
[No Abstract] [Full Text] [Related]
3. Risk of urothelial cancer death among people using antihypertensive drugs-a cohort study from Finland.
Santala EEE; Kotsar A; Veitonmäki T; Tammela TLJ; Murtola TJ
Scand J Urol; 2019 Aug; 53(4):185-192. PubMed ID: 31250699
[No Abstract] [Full Text] [Related]
4. Beta-Blocker Drug Use and Survival among Patients with Pancreatic Adenocarcinoma.
Udumyan R; Montgomery S; Fang F; Almroth H; Valdimarsdottir U; Ekbom A; Smedby KE; Fall K
Cancer Res; 2017 Jul; 77(13):3700-3707. PubMed ID: 28473530
[TBL] [Abstract][Full Text] [Related]
5. Beta-Blocker Use and Lung Cancer Mortality in a Nationwide Cohort Study of Patients with Primary Non-Small Cell Lung Cancer.
Udumyan R; Montgomery S; Fang F; Valdimarsdottir U; Hardardottir H; Ekbom A; Smedby KE; Fall K
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):119-126. PubMed ID: 31641010
[TBL] [Abstract][Full Text] [Related]
6. Effects of beta-blocker therapy on mortality after elective colon cancer surgery: a Swedish nationwide cohort study.
Ahl R; Matthiessen P; Sjölin G; Cao Y; Wallin G; Ljungqvist O; Mohseni S
BMJ Open; 2020 Jul; 10(7):e036164. PubMed ID: 32641361
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
[TBL] [Abstract][Full Text] [Related]
8. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
9. Association between use of β-blockers and prostate cancer-specific survival: a cohort study of 3561 prostate cancer patients with high-risk or metastatic disease.
Grytli HH; Fagerland MW; Fosså SD; Taskén KA
Eur Urol; 2014 Mar; 65(3):635-41. PubMed ID: 23351721
[TBL] [Abstract][Full Text] [Related]
10. Sex Differences in Urothelial Bladder Cancer Survival.
Radkiewicz C; Edgren G; Johansson ALV; Jahnson S; Häggström C; Akre O; Lambe M; Dickman PW
Clin Genitourin Cancer; 2020 Feb; 18(1):26-34.e6. PubMed ID: 31787542
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of Pembrolizumab as Second-line Therapy for the Treatment of Locally Advanced or Metastatic Urothelial Carcinoma in Sweden.
Srivastava T; Prabhu VS; Li H; Xu R; Zarabi N; Zhong Y; Pellissier JM; Perini RF; de Wit R; Mamtani R
Eur Urol Oncol; 2020 Oct; 3(5):663-670. PubMed ID: 31412001
[TBL] [Abstract][Full Text] [Related]
12. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease.
Fu EL; Uijl A; Dekker FW; Lund LH; Savarese G; Carrero JJ
Circ Heart Fail; 2020 Nov; 13(11):e007180. PubMed ID: 33070637
[TBL] [Abstract][Full Text] [Related]
13. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium.
Mir MC; Marchioni M; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; McGrath JS; Kassouf W; Dall'Era MA; Sridhar SS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand D; Black PC
Eur Urol Focus; 2021 Nov; 7(6):1347-1354. PubMed ID: 32771446
[TBL] [Abstract][Full Text] [Related]
14. An International Multicenter Cohort Study on β-Blockers for the Treatment of Symptomatic Children With Catecholaminergic Polymorphic Ventricular Tachycardia.
Peltenburg PJ; Kallas D; Bos JM; Lieve KVV; Franciosi S; Roston TM; Denjoy I; Sorensen KB; Ohno S; Roses-Noguer F; Aiba T; Maltret A; LaPage MJ; Atallah J; Giudicessi JR; Clur SB; Blom NA; Tanck M; Extramiana F; Kato K; Barc J; Borggrefe M; Behr ER; Sarquella-Brugada G; Tfelt-Hansen J; Zorio E; Swan H; Kammeraad JAE; Krahn AD; Davis A; Sacher F; Schwartz PJ; Roberts JD; Skinner JR; van den Berg MP; Kannankeril PJ; Drago F; Robyns T; Haugaa K; Tavacova T; Semsarian C; Till J; Probst V; Brugada R; Shimizu W; Horie M; Leenhardt A; Ackerman MJ; Sanatani S; van der Werf C; Wilde AAM
Circulation; 2022 Feb; 145(5):333-344. PubMed ID: 34874747
[TBL] [Abstract][Full Text] [Related]
15. Associations between β-blockers and psychiatric and behavioural outcomes: A population-based cohort study of 1.4 million individuals in Sweden.
Molero Y; Kaddoura S; Kuja-Halkola R; Larsson H; Lichtenstein P; D'Onofrio BM; Fazel S
PLoS Med; 2023 Jan; 20(1):e1004164. PubMed ID: 36719888
[TBL] [Abstract][Full Text] [Related]
16. Beta-blocker use and mortality following ovarian cancer diagnosis: a population-based study.
Couttenier A; Lacroix O; Silversmit G; Vaes E; De Schutter H; Robert A
Cancer Epidemiol; 2019 Oct; 62():101579. PubMed ID: 31450179
[TBL] [Abstract][Full Text] [Related]
17. Pathological and Survival Outcomes Associated with Variant Histology Bladder Cancers Managed by Cystectomy with or without Neoadjuvant Chemotherapy.
Hajiran A; Azizi M; Aydin AM; Zemp L; Peyton CC; Dhillon J; Nealon S; Reich RR; Cao B; Li R; Manley BJ; Sexton WJ; Gilbert SM
J Urol; 2021 Jan; 205(1):100-108. PubMed ID: 32783489
[TBL] [Abstract][Full Text] [Related]
18. Association Between Perioperative Chemotherapy and Survival in Men Undergoing Radical Resection for Primary Urethral Urothelial Carcinoma: An Analysis of the National Cancer Database.
Celtik K; Lim K; Dursun F; Xu J; Klaassen Z; Zhang J; Efstathiou E; Sonpavde G; Wallis C; Satkunasivam R
Clin Genitourin Cancer; 2022 Jun; 20(3):244-251. PubMed ID: 35181268
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant chemotherapy versus observation following radical cystectomy for locally advanced urothelial carcinoma of the bladder.
Bharadwaj M; Kaul S; Fleishman A; Korets R; Chang P; Wagner A; Kim S; Bellmunt J; Kaplan I; Olumi AF; Gershman B
Urol Oncol; 2022 Jun; 40(6):274.e15-274.e23. PubMed ID: 35307291
[TBL] [Abstract][Full Text] [Related]
20. Pre-operative beta-blocker therapy does not affect short-term mortality after esophageal resection for cancer.
Reda S; Ahl R; Szabo E; Stenberg E; Forssten MP; Sjolin G; Cao Y; Mohseni S
BMC Surg; 2020 Dec; 20(1):333. PubMed ID: 33353542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
